AGVHD PROPHYLAXIS

Clinical trials for AGVHD PROPHYLAXIS explained in plain language.

Never miss a new study

Get alerted when new AGVHD PROPHYLAXIS trials appear

Sign up with your email to follow new studies for AGVHD PROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope to shield transplant patients from dangerous immune attack

Disease control Not yet recruiting

This study is testing whether adding a new drug called gecacitinib to standard treatment can better prevent a dangerous immune reaction called acute Graft-Versus-Host Disease (aGVHD) in patients with myelofibrosis. It will involve 40 adults with advanced myelofibrosis who are rec…

Matched conditions: AGVHD PROPHYLAXIS

Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

AGVHD PROPHYLAXIS

Get alerted when new AGVHD PROPHYLAXIS trials appear

New hope to shield transplant patients from dangerous immune attack